Related Experiment Video
Updated: Apr 3, 2026

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
High-altitude thrombosis: divergent pathophysiological mechanisms and preventive strategies in acutely exposed
Meiquan Li1, Jinrui Guo2, Meiwei Zhao1
1College of Agriculture and Life Sciences, Kunming University, Kunming, Yunnan, China.
Purpose Of Review:
High-altitude environments pose distinct physiological challenges, with marked differences in the thrombotic responses between high-altitude acutely exposed individuals (HAAEI) and long-term high-altitude natives (HAN). This narrative review explores the divergent mechanisms underlying thrombosis in these two populations, aiming to deepen understanding of hypoxia-induced vascular risk.
Recent Findings:
Acute high-altitude exposure elicits a cascade of responses-including sympathetic overactivation, inflammation, polycythemia, increased blood viscosity, and endothelial dysfunction-that collectively heighten thrombosis risk. Central to this process is the hypoxia-mediated interaction of HIF with NF-κB pathways, which fosters a proinflammatory and procoagulant milieu characterized by cytokine upregulation, enhanced platelet activation, and suppressed fibrinolysis. Conversely, HAN exhibit genetic and physiological adaptations-such as improved oxygen utilization and hematological efficiency-that confer relative protection. However, extreme hypoxia or dehydration can override these adaptations, triggering pathological hyperviscosity. Prevention strategies for HAAEI include gradual acclimatization, hydration, and activity moderation, while HAN may benefit from routine hematological monitoring and, if necessary, antithrombotic interventions.
Plain Language Summary:
Hypoxia-induced alterations in inflammation and blood rheology play pivotal roles in high-altitude thrombosis. Population-specific prevention strategies are essential, and further research is needed to refine pathophysiological understanding and guide targeted interventions.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management
